BCC vs MD
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BCC · Boise Cascade$70.24 ▼ 4.76%
MD · Pediatrix Medical$31.29 ▼ 1.73%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BCC +1.8%
- MD +38.6%
Head to head
| Metric | BCC | MD |
|---|---|---|
| Price | $70.24 | $31.29 |
| Change today | ▼ 4.76% | ▼ 1.73% |
| Market cap | $2.44B | $2.44B |
| Return, 3 months | -16.9% | +20.0% |
| Return, year to date | -3.7% | +46.3% |
| Return, 1 year | +0.6% | +42.7% |
| P/E (TTM) | 20.7 | 17.1 |
| P/B | 1.2 | 2.9 |
| P/E percentile vs own 5y | 98th | 79th |
| Dividend yield | 1.27% | – |
| Revenue growth (YoY, latest qtr) | +5.2% | +1.7% |
| Net profit growth (YoY) | -7.5% | -34.5% |
| Gross margin | 16.5% | 26.1% |
| Operating margin | 2.5% | 12.1% |
| Net margin | 1.6% | 7.7% |
| Return on equity | 5.1% | 17.2% |
| Analyst target vs. price | +32.7% | -12.4% |
| Analyst buy share | 50% | 17% |
| RSI (14) | 39 | 67 |
| 30-day volatility | 39.0% | 32.8% |
| Max drawdown, 1 year | -27.9% | -23.7% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BCC is the largest of the group by market value.
- MD has returned the most over the past year.
- MD carries the lowest trailing P/E.
- BCC is growing revenue fastest.
- MD keeps the most profit per dollar of sales.
- MD has been the calmest stock over the last 30 days.